Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 95

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 95
---
 loss of key personnel and the inability to replace such personnel on a timely basis or on acceptable terms; •changes in applicable laws or regulations; 22 •the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; and •the outcome of any known and unknown litigation and regulatory proceedings. These forward -lookingstatements are based on information available as of the date of this proxy statement/prospectus, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward -lookingstatements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward -lookingstatements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. 23 Risk Factors In addition to the other information contained in (or incorporated by reference into) this proxy statement / prospectus, including the matters addressed under the heading “ Forward -Looking Statements,” you should carefully consider the following risk factors in deciding how to vote on the proposals presented in this proxy statement / prospectus. The occurrence of one or more of the events or circumstances described in these risk factors, alone or in combination with other events or circumstances, may have a material adverse effect on the Company business, reputation, revenue, financial condition, results of operations and future prospects, in which event the market price of the Company Shares could decline, and you could lose part or all of your investment. Unless otherwise indicated, reference in this section and elsewhere in this proxy statement / prospectus to the Company business being adversely affected, negatively impacted or harmed will include an adverse effect on, or a negative impact or harm to, the business, reputation, financial condition, results of operations, revenue and future prospects of the Company. Risks Related to Our Business and Strategy Our growth and success depend on our ability to develop current and new products to grow our presence in the personal genetics market. Our success in the personal genetics market depends on our ability to grow our market position, develop new services, provide customers with high -qualitytest reports quickly and at a lower price than our competitors, and achieve sufficient test and related services volume to realize economies of scale. To do this, we must significantly scale our infrastructure, including our testing capacity and information systems, expand our commercial operations, customer service, billing and systems processes, and enhance our internal quality assurance program. We must also innovate and